With the market for healthcare apps to “quadruple to $400 million by 2016,” it should be no surprise that the Food and Drug Administration (FDA) plans to regulate these emerging mobile technologies.[i] Changing how consumers interact with the healthcare system and the increasing market growth, healthcare mobile apps are requiring the FDA to take a regulatory stance on these new platforms. On September 25, 2013, the FDA released Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff which outlines their plan for regulating mobile apps (Guidance).[ii].
An ABA Health Law Section exclusive from the eHealth, Privacy & Security Interest Group. Please login with your ABA ID and password to read the entire article.